000 04553nam a22006255i 4500
001 978-3-031-52864-4
003 DE-He213
005 20250516160018.0
007 cr nn 008mamaa
008 240329s2024 sz | s |||| 0|eng d
020 _a9783031528644
_9978-3-031-52864-4
050 4 _aRS1-441
072 7 _aMQP
_2bicssc
072 7 _aMED072000
_2bisacsh
072 7 _aMQP
_2thema
082 0 4 _a615.1
_223
245 1 0 _aDrug Delivery and Targeting
_h[electronic resource] /
_cedited by Monika Schäfer-Korting, Ulrich S. Schubert.
250 _a1st ed. 2024.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2024.
300 _aX, 411 p. 70 illus.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aHandbook of Experimental Pharmacology,
_x1865-0325 ;
_v284
505 0 _aPart I. Nanoparticles and other Advanced Technologies -- Knowledge-based design of multi-functional polymer-based nanoparticles -- Stimuli-responsive non-viral nanoparticles for gene delivery -- Sustainability in drug and nano-particle processing -- Advanced formulation approaches for proteins -- Microneedles and polymer films - delivery of peptides, proteins and nucleic acids -- Advances in vaccine delivery enhancers - small molecules and nanomaterials -- Biodegradable long acting injectables: Platform technology and industrial challenges -- Part II. Visualization Technologies -- Visualization of Nano-carriers and Drugs in Cells and Tissue -- Characterization of drug delivery systems by transmission electron microscopy -- Part III. Target Specific Delivery -- Blood-brain barrier-crossing strategies for improved treatment of CNS disorders -- Interactions of nano-systems with immune cells and cancer cells - a roadmap to clinical use?- Progress in ocular drug delivery: challenges and constraints -- New therapeutic options in pulmonal diseases - sphingolipids and sphingolipid metabolism -- Molecular therapeutics for pulmonary diseases - the need for drug targeting -- Delivery of mitochondrial RNA -- Part IV. Concerted Actions - Thinking the Drug from the Beginning -- ATMP formulations and delivery -- Preclinical testing and approval of ATMP -- Looking to the future - drug delivery in the prophylaxis and therapy of severe and chronic diseases.
520 _aSince the publication of the Handbook of Experimental Pharmacology Vol. 197 in 2010 there have been important advances in drug development, drug delivery and - more recently - drug targeting. This is in particular relevant with the new generation of drugs acting on the immune system and tumors. These are quite often accompanied by major adverse reactions. Safe therapy is, therefore, an important area of research, in particular in chronic diseases and in persons of old age. In addition, the Covid-19 pandemic has brought renewed attention to vaccinations against viral infections, and mRNA vaccines have been tested for vaccination in tumor therapy, too. Vaccine delivery has stimulated important research on carriers which may pave the way for other applications and enhance a path to e.g. CRISPR-cas therapy.
541 _fUABC ;
_cPerpetuidad
650 0 _aPharmacy.
650 0 _aPharmacology.
650 0 _aMedicine
_xResearch.
650 0 _aBiology
_xResearch.
650 0 _aClinical medicine
_xResearch.
650 0 _aPharmacovigilance.
650 1 4 _aPharmacy.
650 2 4 _aPharmacology.
650 2 4 _aTranslational Research.
650 2 4 _aClinical Research.
650 2 4 _aDrug Safety and Pharmacovigilance.
700 1 _aSchäfer-Korting, Monika.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aSchubert, Ulrich S.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783031528637
776 0 8 _iPrinted edition:
_z9783031528651
776 0 8 _iPrinted edition:
_z9783031528668
830 0 _aHandbook of Experimental Pharmacology,
_x1865-0325 ;
_v284
856 4 0 _zLibro electrónico
_uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-3-031-52864-4
912 _aZDB-2-SBL
912 _aZDB-2-SXB
942 _cLIBRO_ELEC
999 _c274654
_d274653